Government ‘Home Visits’ to Pharma Employees During Investigations Are on the Rise

Federal investigators are increasingly resorting to unannounced visits to the homes of drugmakers’ employees to question them during investigations, and companies should take steps to prepare if facing government scrutiny, an industry attorney says.
Drug Industry Daily